The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...
Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...
From using the right filing status to checking if you qualify for an extension, NBC senior business analyst Stephanie Ruhle ...
RuPaul’s Drag Race alum Peppermint revealed that she’s lost 100 lbs. with the help of weight-loss injections. The 45-year-old ...
Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics.
4d
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health ...
Weight loss medications like Wegovy and Zepbound can be effective but may pose risks for older adults, including muscle loss and bone density decline.
The exact price depends on dosage, pharmacy, location, insurance coverage, and available savings programs. Fully understanding the various factors affecting ...
Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback